• 1
    Australian Institute of Health and Welfare (AIHW). 2010 National Drug Strategy Household Survey Report. Drug Statistics Series no. 25. Canberra, AIHW. 2011.
  • 2
    Australian Institute of Health and Welfare (AIHW). Australia's Health, 2002. Canberra, AIHW. 2002.
  • 3
    Richmond R. L., Butler T., Belcher J. M., Wodak A., Wilhelm K. A., Baxter E. Promoting smoking cessation among prisoners: feasibility of a multi-component intervention. Aust NZ J Public Health 2006; 30: 474478.
  • 4
    Butler T., Lim D., Callander D. National Prison Entrants' Bloodborne Virus and Risk Behaviour Survey Report 2004, 2007 and 2010. Sydney: Kirby Institute (University of New South Wales) and National Drug Research Institute (Curtin University); 2011, ISBN: 978-0-7334-3055-8.
  • 5
    Baker A., Ivers R., Bowman J., Butler T., Kay-Lambkin F. J., Wye P. et al. Where there's smoke, there's fire: high prevalence of smoking among some sub-populations. Drug Alcohol Rev 2006; 25: 8596.
  • 6
    Polgar S., McGartland M., Borlongan C. V., Shytle R. D., Sanberg P. R. Smoking cessation programmes are neglecting the needs of persons with neuropsychiatric disorders. Aust NZ J Med 1996; 26: 572573.
  • 7
    Indig D., Topp L., Ross B., Mamoon H., Border B., Kumar S. et al. 2009 NSW Inmate Health Survey: Key Findings Report. Sydney: Justice Health; 2010.
  • 8
    Butler T., Milner L. The 2001 Inmate Health Survey. Sydney: NSW Corrections Health Service; 2003, ISBN: 0 7347 3560 X.
  • 9
    Hockings B., Young M., Falconer A., O'Rourke P. K. Queensland Women Prisoners' Health Survey. Brisbane: Department of Corrective Services; 2002.
  • 10
    Butler T. Preliminary Findings of the NSW Inmate Health Survey. Sydney: NSW Corrections Health Service; 1997, ISBN: 07313 40981.
  • 11
    Butler T., Allnutt S. Mental Illness among New South Wales Prisoners. Sydney: NSW Corrections Health Service; 2003, ISBN: 0 7347 3559 6.
  • 12
    Butler T., Andrews G., Allnutt S., Smith N., Sakashita C., Basson J. Mental disorders in Australian prisoners: a comparison with a community sample. Aust NZ J Psychiatry 2006; 40: 272276.
  • 13
    Wilhelm K., Arnold K., Niven H., Richmond R. Grey lungs and blue moods. Aust NZ J Psychiatry 2004; 27: 411421.
  • 14
    Australian Bureau of Statistics. Prisoners in Australia, 2010. ABS Catalogue number 4517.0. Canberra: Australian Bureau of Statistics; 2010.
  • 15
    Belcher J., Butler T., Richmond R., Wodak A., Wilhelm K. Smoking and its correlates in an Australian prisoner population. Drug Alcohol Rev 2006; 25: 343348.
  • 16
    Cropsey K., Eldridge G., Ladner T. Smoking among female prisoners: an ignored public health epidemic. Addict Behav 2004; 29: 425431.
  • 17
    Cropsey K., Linker J., Waite D. An analysis of racial and sex differences for smoking among adolescents in a juvenile correctional centre. Drug Alcohol Depend 2008; 92: 156163.
  • 18
    Singleton N., Farrell M., Meltzer H. Substance misuse among prisoners in England and Wales. Int Rev Psychiatry 2003; 15: 150152.
  • 19
    Fazel S., Hope T., O'Donnell I., Piper M., Jacoby R. Health of elderly male prisoners: worse than the general population, worse than younger prisoners. Age Ageing 2001; 30: 403407.
  • 20
    Sieminska A., Jassem E., Konopa K. Prisoners' attitudes towards cigarette smoking and smoking cessation: a questionnaire study in Poland. BMC Public Health 2006; 6: 181.
  • 21
    Awofeso N. Implementing smoking cessation programmes in prison settings. Addict Res Theory 2003; 11: 119130.
  • 22
    Cropsey K., Jackson D., Hale G. J., Carpenter M. J., Stitzer M. L. Impact of self-initiated pre-quit smoking reduction on cessation rates: results of a clinical trial of smoking cessation among female prisoners. Addict Behav 2011; 36: 7378.
  • 23
    Cropsey K. L., Kristeller J. L. Motivational factors related to quitting smoking among prisoners during a smoking ban. Addict Behav 2003; 28: 10811093.
  • 24
    Cropsey K. L., Kristeller J. L. The effects of a prison smoking ban on smoking behavior and withdrawal symptoms. Addict Behav 2005; 30: 589594.
  • 25
    Kauffman R., Ferketich A., Murray D., Bellair P., Wewers M. Tobacco use by male prisoners under an indoor smoking ban. Nicotine Tob Res 2011; 13: 449456.
  • 26
    Cropsey K., Eldridge G., Weaver M., Villalobos G., Stitzer M., Best A. Smoking cessation intervention for female prisoners: addressing an urgent public health need. Am J Public Health 2008; 98: 18941901.
  • 27
    Cropsey K., Weaver M., Eldridge G., Villalobos G., Best A., Stitzer M. Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners. Nicotine Tob Res 2009; 11: 690697.
  • 28
    Stead L. F., Perera R., Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2006; (3): CD002850.
  • 29
    Stead L. F., Perera R., Bullen C., Mant D., Lancaster T. Nicotine replacement for smoking cessation. Cochrane Database Syst Rev 2008; (1): CD000146, publication 3.
  • 30
    Lancaster T., Stead L. F. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2005; (2): CD001292.
  • 31
    Hughes J. R., Stead L. F., Lancaster T. Antidepressants for smoking cessation (Cochrane Review). The Cochrane Library 2003. Cochrane Database Syst Rev 2007; (1): CD000031, publication 3, 2003.
  • 32
    Zwar N., Richmond R., Borland R., Peters M., Stillman S., Litt J. et al. Smoking cessation pharmacotherapy: an update for health professionals. Melbourne: Royal Australian College of General Practitioners. 2007.
  • 33
    Hall S. M., Humfleet G. L., Reus V. I., Muñoz R. F., Cullen J. Extended nortriptyline and psychological treatment for cigarette smoking. Am J Psychiatry 2004; 161: 21002107.
  • 34
    Hall S. M., Reus V. I., Muñoz R. F., Sees K. L., Humfleet G., Hartz D. T. et al. Nortriptyline and cognitive–behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998; 55: 683690.
  • 35
    Fiore M. A clinical practice guideline for treating tobacco use and dependence: a US public health service report. JAMA 2000; 283: 32443254.
  • 36
    Heatherton T., Kozlowski L., Frecker R., Fagerström K. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86: 11191127.
  • 37
    Crittenden K. S., Manfredi C., Lacey L., Warnecke R., Parsons J. Measuring readiness and motivation to quit smoking among women in public health clinics. Addict Behav 1994; 19: 497507.
  • 38
    Prochaska A. V., Reyes R., Steinbrunn C., Miyoshi T. Randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. Society for Research on Nicotine and Tobacco 7th Annual Meeting, March 23–25: Seattle, Washington; 2001; 73 [abstract book].
  • 39
    Hughes J. R., Keely J. P., Niaura R. S., Ossip-Klein D. J., Richmond R. L., Swan G. E. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003; 5: 1325.
  • 40
    Richmond R., Butler T., Wilhelm K., Wodak A., Indig I. Handbook of the Behavioural Intervention for Smoking Cessation to Use Among Prisoners. 2012. Available at: (accessed 21 May 2012).
  • 41
    Lichtenstein E., Glasgow R. E., Lando H. A., Ossip-Klein D. J., Boles S. M. Telephone counselling for smoking cessation: rationales and meta-analytic review of evidence. Health Educ Res 1996; 11: 243257.
  • 42
    Borland R., Segan C. J., Livingston P. M., Owen N. The effectiveness of callback counselling for smoking cessation: a randomized trial. Addiction 2001; 96: 881889.
  • 43
    Hughes J. R., Carpenter M. J. The feasibility of smoking reduction: an update. Addiction 2005; 100: 10741089.
  • 44
    Wright C. C., Sim J. Intention to treat approach to data from randomised controlled trials: a sensitivity analysis. J Clin Epidemiol 2003; 56: 833842.
  • 45
    Hughes J. R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986; 43: 289294.
  • 46
    Hughes J. R. Tobacco withdrawal in self-quitters. J Consult Clin Psychol 1992; 60: 689697.
  • 47
    Beck A. T., Ward C., Mendelson M. Beck Depression Inventory (BDI). Arch Gen Psychiatry 1961; 4: 561571.
  • 48
    Kessler R. C., Andrews G., Colpe L. J., Hiripi E., Mroczek D. K., Normand S. et al. Short screening scales to monitor population prevalences and trends in nonspecific psychological distress. Psychol Med 2002; 32: 959976.
  • 49
    Ware J. E., Kosinski M., Keller S. D. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute; 1994.
  • 50
    Aveyard P., Johnson C., Fillingham S., Parson A., Murphy M. Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation; pragmatic randomised controlled trial. BMJ 2008; 336: 12231227.
  • 51
    Harris J. E., Thun M. J., Mondul A. M., Calle E. E. Cigarette tar yields in relation to morality from lung cancer in the cancer prevention study II prospective cohort, 1982–8. BMJ 2004; 328: 72.
  • 52
    Kabat G. C. Fifty years' experience of reduced-tar cigarettes: what do we know about their health effects? Inhal Toxicol 2003; 15: 10591102.
  • 53
    Richmond R., Wilhelm K., Indig D., Butler T. G., Archer V. A., Wodak A. D. Cardiovascular risk among Aboriginal and non-Aboriginal smoking male prisoners: inequalities compared to the wider community. BMC Public Health 2011; 11: 783.
  • 54
    Kariminia A., Butler T., Corben S., Levy M., Grant L., Kaldor J. Extreme cause specific mortality among adults who have served time in prison: a cohort study. Int J Epidemiol 2007; 36: 310316.
  • 55
    Hughes J. R. Reducing smoking: an introduction and review of the evidence. Addiction 2000; 95: S37.
  • 56
    Rose J. E., Behm F. M. Extinguishing the rewarding value of smoke cues: pharmacological and behavioural treatments. Nicotine Tob Res 2004; 6: 523532.
  • 57
    Carpenter M. J., Hughes J. R., Keely J. P. Effect of smoking reduction on later cessation: a pilot experimental study. Nicotine Tob Res 2003; 5: 155162.
  • 58
    Alterman A. I., Gariti P., Cook T. G., Cnaan A. Nicodermal patch adherence and its correlates. Drug Alcohol Depend 1999; 53: 159165.
  • 59
    Cummings K. M., Biernbaum R. P., Zevon M. A., Deloughry T., Jaen C. R. Use and effectiveness of transdermal nicotine in primary care settings. Arch Fam Med 1994; 3: 682689.
  • 60
    Fiore M. C., Smith S. S., Jorenby D. E., Baker T. The effectiveness of the nicotine patch for smoking cessation. JAMA 1994; 271: 19401947.
  • 61
    Wu P., Wilson K., Dimoulas P., Mills E. J. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 2006; 6: 300.
  • 62
    Silagy C., Lancaster T., Stead L. F., Mant D., Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2002; (4): CD000146.
  • 63
    Richmond R., Butler T., Wilhelm K., Wodak A., Cunningham M., Anderson I. Tobacco in prisons: a focus group study. Tob Control 2009; 19: 176182.
  • 64
    Mohr S., Hopewell S., Schulz K., Montori V. M., Gotzsche P., Devereaux P. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: C869.
  • 65
    West R., Hajek P., Stead L., Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005; 100: 299303.
  • 66
    Society for Research on Nicotine and Tobacco (SRNT) Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4: 149159.
  • 67
    McChargue D. E., Gulliver S. B., Hitsman B. Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment? Addiction 2002; 100: 10741089.